Vendors are deploying organic and inorganic growth strategies to compete in the market.
NEW YORK, Sept. 13, 2022 /PRNewswire/ -- One of the key vendors operating in the immunology market is AbbVie Inc. The company offers an immunology product named HUMIRA. The market also has the presence of a few other major players, such as Amgen Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Johnson and Johnson Inc., and Novartis AG.
Challenges Faced by Immunology Market Vendors
The immunology market is fragmented. The market is expected to witness intense competition among vendors because of the adoption of disruptive strategies. The global immunology market also compromises new academic start-ups. Due to the lack of financial backing, these small immunology drug players with high-potential products are being acquired by bigger players. Moreover, intense competition and declining profit margins are significant risk factors for the vendors.
Key Vendor Strategies to Overcome Market Challenges
Key strategies used by vendors to overcome the above challenges have been identified by Technavio. The opportunities for new entrants in the development of immunomodulatory therapies will be enhanced, with the expiry of patents of branded therapeutics in anti-histamines, B/T-cell suppressive agents, and corticosteroids. Therefore, to survive and succeed in this intensely competitive environment, it becomes imperative for vendors to differentiate their product and service offerings through clear and unique value propositions.
Technavio's reports provide key strategic initiatives used by vendors, along with key news and the latest developments. View our FREE PDF Sample Report Now
Market Growth Potential
The immunology market size is expected to grow by USD 55.00 billion from 2021 to 2025. In addition, the growth momentum of the market will accelerate at a CAGR of 8.45% during the forecast period.
Technavio provides a comprehensive report summary describing the market size and forecast along with research methodology. The sample report is available in PDF format
Factors that will Drive the Market
Vendors in the immunology market can take advantage of a few factors that will work in their favor. One of these factors includes growing organ transplantation. Ongoing commitment and combined efforts of organ procurement organizations, hospitals, and the Organ Procurement and Transplantation Network (OPTN) are contributing to the rise in organ transplantations. Thus, the increasing number of organ transplantations is expected to drive the demand for immunosuppressive drugs, which, in turn, will fuel the growth of the global immunology market during the forecast period.
Technavio has identified key trends, drivers, and challenges in the market, which will help vendors improve their strategies to stay ahead of their competitors. View our FREE PDF Sample Report
Pharmacogenomics Market by End-user and Geography - Forecast and Analysis 2022-2026: The market's varying regulations on pharmacogenomics testing and research globally are challenging market growth.
Clinical Trial Support Services Market Application, Age Group, and Geography - Forecast and Analysis 2022-2026: High cost of clinical trials may challenge the market growth
Immunology Market Scope
Growth momentum & CAGR
Accelerate at a CAGR of 8.45%
Market growth 2021-2025
USD 55.00 billion
YoY growth (%)
North America, Europe, Asia, and ROW
Performing market contribution
North America at 40%
Key consumer countries
US, Germany, UK, China, and Japan
Leading companies, Competitive strategies, Consumer engagement scope
AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Johnson and Johnson Inc., Novartis AG, Pfizer Inc., Sumitomo Dainippon Pharma Co. Ltd., Takeda Pharmaceutical Co. Ltd., and UCB SA
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and Market condition analysis for the forecast period.
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
Browse Health Care Market Reports
Table of Contents
Value chain analysis
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market Segmentation by Category
Comparison by Category
Immunosuppressants - Market size and forecast 2020-2025
Immuno boosters - Market size and forecast 2020-2025
Market opportunity by Category
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity by geography
Market positioning of vendors
Bristol-Myers Squibb Co.
F. Hoffmann-La Roche Ltd.
Johnson and Johnson Inc.
Sumitomo Dainippon Pharma Co. Ltd.
Takeda Pharmaceutical Co. Ltd.
Scope of the report
Currency conversion rates for US$
List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
View original content to download multimedia:https://www.prnewswire.com/news-releases/immunology-market-a-deep-dive-into-factors-that-will-help-vendors-stay-ahead-of-competitors--technavio-301623096.html